Oral delivery of exenatide-loaded hybrid zein nanoparticles for stable blood glucose control and β-cell repair of type 2 diabetes mice
Exenatide is an insulinotropic peptide drug for type 2 diabetes treatment with low risk of hypoglycemia, and is administrated by subcutaneous injection. Oral administration is the most preferred route for life...
Source: Journal of Nanobiotechnology - Category: Nanotechnology Authors: Xiaoyan Bao, Kang Qian and Ping Yao Tags: Research Source Type: research
More News: Byetta | Diabetes | Diabetes Type 2 | Endocrinology | Gastroschisis Repair | Nanotechnology